|
This bill requires
carriers offering health plans in this State to provide coverage for blood
testing for perfluoroalkyl and polyfluoroalkyl substances. The requirements
of the bill apply to health plans issued or renewed on or after January 1,
2027. The bill includes General Fund appropriations to the Department of
Administrative and Financial Services of $90,000 for the estimated cost to
reimburse the insurance carriers, for 6 months of the State's defrayal cost
of this new mandate. The mandate will go into effect on all health insurance
plans on the marketplace beginning January 1, 2027 and is estimated to cost
$180,000 annually, thereafter.
The State Employee Health Plan's first impacted plan year will be fiscal
year 2027-28 and is estimated to cost $57,313 annually thereafter. The costs
are split across the General Fund ($26,364), Highway Fund ($9,170) and all
other funds ($21,779). |